# Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.

> **NCT02067117** · PHASE4 · COMPLETED · sponsor: **Green Cross Corporation** · enrollment: 1139 (actual)

## Conditions studied

- Prevention of Influenza

## Interventions

- **DRUG:** GC FLU® Injection, GC FLU® Pre-filled Syringe Injection

## Key facts

- **NCT ID:** NCT02067117
- **Lead sponsor:** Green Cross Corporation
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2010-11
- **Final completion:** 2010-11
- **Target enrollment:** 1139 (ACTUAL)
- **Last updated:** 2014-02-20


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02067117

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02067117, "Demonstrate the Lot-to-lot Consistency of 3 Consecutive Batches and to Evaluate the Efficacy and Safety of GC FLU®Pre-filled Syringe Injection and 'GC FLU®Injection' Administration.". Retrieved via AI Analytics 2026-06-23 from https://api.ai-analytics.org/clinical/NCT02067117. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*